60 Degrees Pharmaceuticals IncHere is the public summary page for 60 Degrees Pharmaceuticals Inc. Please login to see the complete information for 60 Degrees Pharmaceuticals Inc including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how 60 Degrees Pharmaceuticals Inc stacks up relative to its peers. |
| Darwin Score | -2 |
| Ticker | SXTP |
| Latest Price | 1.32 USD as of close on 07-Aug-2025 |
| 3 Month price range | 2.01 to 3.45 USD |
| Market Capitalisation | 3.51Mn USD |
| Country | United States of America |
| Region | North America |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Pharmaceuticals |
| Sub-Industry | Pharmaceuticals |
| Description | 60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventative treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. The company was founded in 2010 and is headquartered in Washington, District Of Columbia. See More ... |
| Company URL | https://www.60degreespharma.com |
| See Darwins Full Analysis for 60 Degrees Pharmaceuticals Inc |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for 60 Degrees Pharmaceuticals Inc. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | -10 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +5 |
| Flow | Institutional, Fund and Insider buying and selling. | +8 |
| Models | Forecast models. | -5 |
Peer Comparison
There are 2 peers of 60 Degrees Pharmaceuticals Inc.
| Asset Name | Industry Group | Asset Score |
|---|---|---|
| Eyenovia Inc (EYEN) | Pharmaceuticals | +15 |
| Traws Pharma Inc (TRAW) | Pharmaceuticals | -22 |
Share 
